Industry Verticals »

All Categories

Insights »

About TMR »

Venous Stents Market

Venous Stents Market (Technology - Iliac Vein Stent Technology, and Wallstent Technology; Application - Leg, Chest, Abdomen, and Arm; Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, and Hemodialysis/Arteriovenous Fistulae) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Global Venous Stents: Snapshot

Venous Stents are mesh tubes, implanted in the veins for chronic symptomatic venous diseases. The venous stents function the same way as that of the arterial stents. They expand against the narrowed or obstructed veins and keep them open. They are the flexible devices used in the peripheral as well as central veins, and act as a scaffold for the vascular walls. Emergence of various efficient technologies for the precise placement of stents in veins, and rising investment of key players in the development of flexible venous stents with high radial strength are the major factors expected to drive the market of venous stents during the forecast period. However, low awareness about the venous interventional procedures in the developing countries is likely to restrain the market growth of venous stents during 2017-2025.

global-venous-stents-market.jpg

Iliac Vein Stent Technology to Maintain Lead throughout Forecast Period

The global venous stents market has been segmented on the basis of technology, application, and disease indication. On the basis of technology, the global venous stents market is divided into iliac vein stent technology, wallstent technology, and such as stenting techniques for long deep veins such as femoral veins, popliteal veins, and veins in the arms. The iliac vein stent technology accounted for the highest market share in terms of revenue in 2016, and is likely to remain leading by 2025. The dominance of Iliac vein stent technology is attributed to the improved access to the deep veins located in the iliac portion with the help of advanced surgical tools. However, Wallstent technology is likely to witness relatively significant CAGR during the forecast period, owing to the pre-marketing approval of Wallstent Endoprosthesis in the U.S. in 2016.

Based on application, the global venous stent market is segmented into leg, chest, abdomen, and arm. The leg application segment accounted for highest revenue in 2016, owing to the emphasis of key players on the venous stents development specifically for femoral & popliteal veins. Chest application segment is estimated to witness maximum CAGR during 2017-2025, which is attributed to the green signal by regulatory authorities for the approval of venous stents for superior vena cava.

On the basis of disease indication, the global venous stents market is divided into chronic deep vein thrombosis (DVT), Post thrombotic syndrome (PTS), May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae, and others. Other disease indication segment is comprised of venous occlusion, re-stenosis, and nutcrackers syndrome. The others segment accounted for highest revenue in 2016, and is likely to remain dominant during the forecast period. However, chronic DVT is projected to register highest CAGR during 2017-2025, owing to the government participation in the venous disease management across the globe.

Strong Presence of Players Puts Europe at Forefront

Geographically, global venous stents market is divided into five major regions, which are North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Europe dominated the global venous stents market in terms of value in 2016. The region is estimated to remain dominant during the forecast period, due to strategic presence of key venous stents manufacturers in Europe. Ongoing clinical trials of venous stents in the U.S., and rising demand for clinically efficient venous interventional devices are the major factors for the estimated growth of venous stents in North America by 2025. However, Asia Pacific is likely to grow with relatively significant CAGR during 2017-2025, due to rising investment by public & private players for the betterment of healthcare services in Asia Pacific region.

Globally, major players operating in the development, manufacturing, and commercialization of venous stents are Boston Scientific Corporation, C. R. Bard, Inc., Jotec GmBH, Veniti, Inc., Gore Medical, Cook Medical, and Optimed Medizinische Instrumente GmBH. 

Growing Incidence of Chronic Veins Diseases to Escalate Growth Rate of Venous Stents Market

The venous stents market is anticipated to invite good growth opportunities across the assessment period of 2017-2025. The growing influence of efficient technologies for the perfect placement of stents in the veins may bring tremendous growth prospects for the venous stents market. The major factor attributed to the growth of the venous stents market is the rising prevalence of diseases such as Nutcracker syndrome, chronic deep vein thrombosis, May-Thurner syndrome, Hemodialysis, and others.

  • The increase in the geriatric population may also prove to be a good growth accelerator for the venous stents market during the forecast period of 2017-2025. The heightening investments by the government bodies of various countries on ramping up the healthcare infrastructure may prove to be a prominent growth contributor for the venous stents market. Furthermore, useful government initiatives and schemes regarding treatment and awareness will further enhance the growth opportunities across the venous stents market.
  • The players in the venous stents market are involved in strategic collaborations such as mergers, acquisitions, partnerships, collaborations, and joint ventures for increasing their influence across the venous stents market. This factor eventually leads to an increase in the growth rate of the venous stents market. Research and development activities are conducted intensively by the players. These activities help the players to derive new formulations and technologies that help in increasing the customer base and eventually the revenues of the players.
  • The novel coronavirus pandemic was a disaster for the entire planet. It affected the livelihood of many individuals. It had a negative impact on many businesses and sectors. The venous stents market was minimally affected due to the pandemic. The border restrictions and disruptions in supply damaged the venous stents market to a great extent. However, the relaxations in lockdown restrictions will help the venous stents market to garner lost growth.

The Global Venous Stents Market has been segmented as given below:

by Technology
  • Iliac Vein Stent Technology
  • Wallstent Technology
  • Others

by Application,
  • Leg
  • Chest
  • Abdomen
  • Arm

by Disease Indication
  • Chronic Deep Vein Thrombosis
  • Post Thrombotic Syndrome
  • May-Thurner Syndrome
  • Hemodialysis/Arteriovenous Fistulae
  • Others

by Region
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa

    1. Preface
          1.1. Market Definition and Scope
          1.2. Market Segmentation
          1.3. Key Research Objectives
          1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global Venous Stents Market

    4. Market Overview
          4.1. Introduction
                  4.1.1. Disease Indication Definition
                  4.1.2. Industry Evolution / Developments
          4.2. Overview
          4.3. Market Dynamics
                  4.3.1. Drivers
                  4.3.2. Restraints
                  4.3.3. Opportunity
          4.4. Global Venous Stents Market Analysis and Forecasts, 2015–2025
          4.5. Market Outlook
          4.6. Product Mapping: Venous Stents
          4.7. Venous Diseases: An Overview
          4.8. Ongoing Clinical Trials: U.S. Snapshot

    5. Global Venous Stents Market Analysis and Forecasts, By Technology 
          5.1. Introduction & Definition
          5.2. Key Findings / Developments
          5.3. Market Value Forecast By Technology, 2015–2025
                  5.3.1. Iliac Vein Stent Technology
                  5.3.2. Wallstent Technology
                  5.3.3. Others
          5.4. Market Attractiveness By Technology

    6. Global Venous Stents Market Analysis and Forecasts, By Application 
          6.1. Introduction & Definition
          6.2. Key Findings / Developments
          6.3. Market Value Forecast By Application, 2015–2025
                  6.3.1. Leg
                  6.3.2. Chest
                  6.3.3. Abdomen
                  6.3.4. Arm
          6.4. Market Attractiveness By Application 

    7. Global Venous Stents Market Analysis and Forecasts, By Disease Indication 
          7.1. Introduction & Definition
          7.2. Key Findings / Developments
          7.3. Market Value Forecast By Disease Indication, 2015–2025
                  7.3.1. Chronic Deep Vein Thrombosis
                  7.3.2. Post Thrombotic Syndrome
                  7.3.3. May-Thurner Syndrome
                  7.3.4. Hemodialysis/Arteriovenous Fistulae
                  7.3.5. Others
          7.4. Market Attractiveness By Disease Indication 

    8. Global Venous Stents Market Analysis and Forecasts, By Region
          8.1. Key Findings
          8.2. Market Value Forecast By Region
                  8.2.1. North America 
                  8.2.2. Europe 
                  8.2.3. Asia Pacific 
                  8.2.4. Latin America 
                  8.2.5. Middle East & Africa 
          8.3. Market Attractiveness By Country/Region

    9. North America Venous Stents Market Analysis and Forecast
          9.1. Introduction
                  9.1.1. Key Findings
          9.2. Market Value Forecast By Technology, 2015–2025
                  9.2.1. Iliac Vein Stent Technology
                  9.2.2. Wallstent Technology
                  9.2.3. Others
          9.3. Market Value Forecast By Application, 2015–2025
                  9.3.1. Leg
                  9.3.2. Chest
                  9.3.3. Abdomen
                  9.3.4. Arm
          9.4. Market Value Forecast By Disease Indication, 2015–2025
                  9.4.1. Chronic Deep Vein Thrombosis
                  9.4.2. Post Thrombotic Syndrome
                  9.4.3. May-Thurner Syndrome
                  9.4.4. Hemodialysis/Arteriovenous Fistulae
                  9.4.5. Others
          9.5. Market Value Forecast By Country, 2015–2025
                  9.5.1. U.S.
                  9.5.2. Canada
          9.6. Market Attractiveness Analysis 
                  9.6.1. By Technology
                  9.6.2. By Application 
                  9.6.3. By Disease Indication 
                  9.6.4. By Country

    10. Europe Venous Stents Market Analysis and Forecast
          10.1. Introduction
                  10.1.1. Key Findings
          10.2. Market Value Forecast By Technology, 2015–2025
                  10.2.1. Iliac Vein Stent Technology
                  10.2.2. Wallstent Technology
                  10.2.3. Others
          10.3. Market Value Forecast By Application, 2015–2025
                  10.3.1. Leg
                  10.3.2. Chest
                  10.3.3. Abdomen
                  10.3.4. Arm
          10.4. Market Value Forecast By Disease Indication, 2015–2025
                  10.4.1. Chronic Deep Vein Thrombosis
                  10.4.2. Post Thrombotic Syndrome
                  10.4.3. May-Thurner Syndrome
                  10.4.4. Hemodialysis/Arteriovenous Fistulae
                  10.4.5. Others
          10.5. Market Value Forecast By Country, 2015–2025
                  10.5.1. Germany
                  10.5.2. U.K.
                  10.5.3. France
                  10.5.4. Spain
                  10.5.5. Italy
                  10.5.6. Rest of Europe
          10.6. Market Attractiveness Analysis 
                  10.6.1. By Technology
                  10.6.2. By Application 
                  10.6.3. By Disease Indication 
                  10.6.4. By Country

    11. Asia Pacific Venous Stents Market Analysis and Forecast
          11.1. Introduction
                  11.1.1. Key Findings      
          11.2. Market Value Forecast By Technology, 2015–2025
                  11.2.1. Iliac Vein Stent Technology
                  11.2.2. Wallstent Technology
                  11.2.3. Others
          11.3. Market Value Forecast By Application, 2015–2025
                  11.3.1. Leg
                  11.3.2. Chest
                  11.3.3. Abdomen
                  11.3.4. Arm
          11.4. Market Value Forecast By Disease Indication, 2015–2025
                  11.4.1. Chronic Deep Vein Thrombosis
                  11.4.2. Post Thrombotic Syndrome
                  11.4.3. May-Thurner Syndrome
                  11.4.4. Hemodialysis/Arteriovenous Fistulae
                  11.4.5. Others
          11.5. Market Value Forecast By Country, 2015–2025
                  11.5.1. China
                  11.5.2. India
                  11.5.3. Australia 
                  11.5.4. Rest of Asia Pacific
          11.6. Market Attractiveness Analysis 
                  11.6.1. By Technology
                  11.6.2. By Application 
                  11.6.3. By Disease Indication 
                  11.6.4. By Country

    12. Latin America Venous Stents Market Analysis and Forecast      
          12.1. Introduction
                  12.1.1. Key Findings
          12.2. Market Value Forecast By Technology, 2015–2025
                  12.2.1. Iliac Vein Stent Technology
                  12.2.2. Wallstent Technology
                  12.2.3. Others
          12.3. Market Value Forecast By Application, 2015–2025
                  12.3.1. Leg
                  12.3.2. Chest
                  12.3.3. Abdomen
                  12.3.4. Arm
          12.4. Market Value Forecast By Disease Indication, 2015–2025
                  12.4.1. Chronic Deep Vein Thrombosis
                  12.4.2. Post Thrombotic Syndrome
                  12.4.3. May-Thurner Syndrome
                  12.4.4. Hemodialysis/Arteriovenous Fistulae
                  12.4.5. Others
          12.5. Market Value Forecast By Country, 2015–2025
                  12.5.1. Brazil
                  12.5.2. Mexico
                  12.5.3. Rest of Latin America
          12.6. Market Attractiveness Analysis 
                  12.6.1. By Technology
                  12.6.2. By Application 
                  12.6.3. By Disease Indication 
                  12.6.4. By Country

    13. Middle East & Africa Venous Stents Market Analysis and Forecast
          13.1. Introduction
                  13.1.1. Key Findings
          13.2. Market Value Forecast By Technology, 2015–2025
                  13.2.1. Iliac Vein Stent Technology
                  13.2.2. Wallstent Technology
                  13.2.3. Others
          13.3. Market Value Forecast By Application, 2015–2025
                  13.3.1. Leg
                  13.3.2. Chest
                  13.3.3. Abdomen
                  13.3.4. Arm
          13.4. Market Value Forecast By Disease Indication, 2015–2025
                  13.4.1. Chronic Deep Vein Thrombosis
                  13.4.2. Post Thrombotic Syndrome
                  13.4.3. May-Thurner Syndrome
                  13.4.4. Hemodialysis/Arteriovenous Fistulae
                  13.4.5. Others
          13.5. Market Value Forecast By Country, 2015–2025
                  13.5.1. GCC Countries
                  13.5.2. South Africa
                  13.5.3. Israel
                  13.5.4. Rest of Middle East & Africa
          13.6. Market Attractiveness Analysis 
                  13.6.1. By Technology
                  13.6.2. By Application 
                  13.6.3. By Disease Indication 
                  13.6.4. By Country

    14. Competition Landscape
          14.1. Market Player – Competition Matrix (By Tier and Size of companies)
          14.2. Market Share Analysis By Company (2016)
          14.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
                  14.3.1. Cook Medical
                             14.3.1.1. Overview
                             14.3.1.2. Financials
                             14.3.1.3. Recent Developments
                             14.3.1.4. SWOT Analysis
                             14.3.1.5. Strategic Overview
                  14.3.2. Optimed Medizinische Instrumente GmbH
                             14.3.2.1. Overview
                             14.3.2.2. Financials
                             14.3.2.3. Recent Developments
                             14.3.2.4. SWOT Analysis
                             14.3.2.5. Strategic Overview
                  14.3.3. W. L. Gore & Associates, Inc. 
                             14.3.3.1. Overview
                             14.3.3.2. Financials
                             14.3.3.3. Recent Developments
                             14.3.3.4. SWOT Analysis
                             14.3.3.5. Strategic Overview
                  14.3.4. VENITI, Inc.
                             14.3.4.1. Overview
                             14.3.4.2. Financials
                             14.3.4.3. Recent Developments
                             14.3.4.4. SWOT Analysis
                             14.3.4.5. Strategic Overview 
                  14.3.5. Jotec GmBH
                             14.3.5.1. Overview
                             14.3.5.2. Financials
                             14.3.5.3. Recent Developments
                             14.3.5.4. SWOT Analysis
                             14.3.5.5. Strategic Overview
                  14.3.6. C. R. Bard, Inc. (BARD Peripheral Vascular)
                             14.3.6.1. Overview
                             14.3.6.2. Financials
                             14.3.6.3. Recent Developments
                             14.3.6.4. SWOT Analysis
                             14.3.6.5. Strategic Overview 
                  14.3.7. Boston Scientific Corporation
                             14.3.7.1. Overview
                             14.3.7.2. Financials
                             14.3.7.3. Recent Developments
                             14.3.7.4. SWOT Analysis
                             14.3.7.5. Strategic Overview

    List of Tables

    Table 01 Product Mapping - Venous Stents
    Table 02 Product Mapping - Venous Stents
    Table 03 Product Mapping - Venous Stents
    Table 04 Ongoing Clinical Trials: U.S. Snapshot
    Table 05 Global Venous Stents Market Size (US$ Mn) Forecast, by Technology, 2015–2025
    Table 06 Global Venous Stents Market Size (US$ Mn) Forecast, by Application, 2015–2025
    Table 07 Global Venous Stents Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
    Table 08 Global Venous Stents Market Size (US$ Mn) Forecast, by Region, 2015–2025
    Table 09 North America Venous Stents Market Size (US$ Mn) Forecast, by Country, 2015–2025
    Table 10 North America Venous Stents Market Size (US$ Mn) Forecast, by Technology, 2015–2025
    Table 11 North America Venous Stents Market Size (US$ Mn) Forecast, by Application, 2015–2025
    Table 12 North America Venous Stents Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
    Table 13 Europe Venous Stents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
    Table 14 Europe Venous Stents Market Size (US$ Mn) Forecast, by Technology, 2015–2025
    Table 15 Europe Venous Stents Market Size (US$ Mn) Forecast, by Application, 2015–2025
    Table 16 Europe Venous Stents Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
    Table 17 Asia Pacific Venous Stents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
    Table 18 Asia Pacific Venous Stents Market Size (US$ Mn) Forecast, by Technology, 2015–2025
    Table 19 Asia Pacific Venous Stents Market Size (US$ Mn) Forecast, by Application, 2015–2025
    Table 20 Asia Pacific Venous Stents Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
    Table 21 Latin America Venous Stents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
    Table 22 Latin America Venous Stents Market Size (US$ Mn) Forecast, by Technology, 2015–2025
    Table 23 Latin America Venous Stents Market Size (US$ Mn) Forecast, by Application, 2015–2025
    Table 24 Latin America Venous Stents Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
    Table 25 Middle East & Africa Venous Stents Market Size (US$ Mn) Forecast, by Country/Sub-Region, 2015–2025
    Table 26 Middle East & Africa Venous Stents Market Size (US$ Mn) Forecast, by Technology, 2015–2025
    Table 27 Middle East & Africa Venous Stents Market Size (US$ Mn) Forecast, by Application, 2015–2025
    Table 28 Middle East & Africa Venous Stents Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025

    List of Figures

    Fig. 01 Global Venous Stents Market Size (US$ Mn) Forecast, 2015–2025
    Fig. 02 Global Venous Stents Market Value Share, by Technology (2016)
    Fig. 03 Global Venous Stents Market Value Share, by Application (2016)
    Fig. 04 Global Venous Stents Market Value Share, by Disease Indication (2016)
    Fig. 05 Global Venous Stents Market Value Share, by Region (2016)
    Fig. 06 Global Venous Stents Market Value Share, by Technology, 2017 and 2025s
    Fig. 07 Global Venous Stents Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Iliac Vein Stent, 2015–2025
    Fig. 08 Global Venous Stents Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Wallstent, 2015–2025
    Fig. 09 Global Venous Stents Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2015–2025
    Fig. 10 Global Venous Stents Market Attractiveness, by Technology, 2017–2025
    Fig. 11 Global Venous Stents Market Value Share, by Application, 2017 and 2025
    Fig. 12 Global Venous Stents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Leg Application, 2015–2025
    Fig. 13 Global Venous Stents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chest Application, 2015–2025
    Fig. 14 Global Venous Stents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Abdomen Application, 2015–2025
    Fig. 15 Global Venous Stents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Arm Application, 2015–2025
    Fig. 16 Global Venous Stents Market Attractiveness, by Application, 2017–2025
    Fig. 17 Global Venous Stents Market Value Share, by Disease Indication, 2017 and 2025
    Fig. 18 Global Venous Stents Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Chronic DVT, 2015–2025
    Fig. 19 Global Venous Stents Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by PTS, 2015–2025
    Fig. 20 Global Venous Stents Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Other Disease Indications, 2015–2025
    Fig. 21 Global Venous Stents Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hemodialysis / Arteriovenous Fistulae, 2015–2025
    Fig. 22 Global Venous Stents Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by May-Thurner Syndrome, 2015–2025
    Fig. 23 Global Venous Stents Market Attractiveness, by Disease Indication, 2017–2025
    Fig. 24 Global Venous Stents Market Value Share, by Region, 2017 and 2025
    Fig. 25 Global Venous Stents Market Attractiveness, by Region, 2017–2025
    Fig. 26 North America Venous Stents Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
    Fig. 27 North America Venous Stents Market Value Share, by Country, 2017 and 2025
    Fig. 28 North America Venous Stents Market Attractiveness, by Country, 2017–2025
    Fig. 29 North America Venous Stents Market Value Share, by Technology, 2017 and 2025
    Fig. 30 North America Venous Stents Market Attractiveness, by Technology, 2017–2025
    Fig. 31 North America Venous Stents Market Value Share, by Application, 2017 and 2025
    Fig. 32 North America Venous Stents Market Attractiveness, by Application, 2017–2025
    Fig. 33 North America Venous Stents Market Value Share, by Disease Indication, 2017 and 2025
    Fig. 34 North America Venous Stents Market Attractiveness, by Disease Indication, 2017–2025
    Fig. 35 Europe Venous Stents Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
    Fig. 36 Europe Venous Stents Market Value Share, by Country/Sub-region, 2017 and 2025
    Fig. 37 Europe Venous Stents Market Attractiveness, by Country/Sub-region, 2017–2025
    Fig. 38 Europe Venous Stents Market Value Share, by Technology, 2017 and 2025
    Fig. 39 Europe Venous Stents Market Attractiveness, by Technology, 2017–2025
    Fig. 40 Europe Venous Stents Market Value Share, by Application, 2017 and 2025
    Fig. 41 Europe Venous Stents Market Attractiveness, by Application, 2017–2025
    Fig. 42 Europe Venous Stents Market Value Share, by Disease Indication, 2017 and 2025
    Fig. 43 Europe Venous Stents Market Attractiveness, by Disease Indication, 2017–2025
    Fig. 44 Asia Pacific Venous Stents Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
    Fig. 45 Asia Pacific Venous Stents Market Value Share, by Country/Sub-region, 2017 and 2025
    Fig. 46 Asia Pacific Venous Stents Market Attractiveness, by Country/Sub-region, 2017–2025
    Fig. 47 Asia Pacific Venous Stents Market Value Share, by Technology, 2017 and 2025
    Fig. 48 Asia Pacific Venous Stents Market Attractiveness, by Technology, 2017–2025
    Fig. 49 Asia Pacific Venous Stents Market Value Share, by Application, 2017 and 2025
    Fig. 50 Asia Pacific Venous Stents Market Attractiveness, by Application, 2017–2025
    Fig. 51 Asia Pacific Venous Stents Market Value Share, by Disease Indication, 2017 and 2025
    Fig. 52 Asia Pacific Venous Stents Market Attractiveness, by Disease Indication, 2017–2025
    Fig. 53 Latin America Venous Stents Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
    Fig. 54 Latin America Venous Stents Market Value Share, by Country/Sub-region, 2017 and 2025
    Fig. 55 Latin America Venous Stents Market Attractiveness, by Country/Sub-region, 2017–2025
    Fig. 56 Latin America Venous Stents Market Value Share, by Technology, 2017 and 2025
    Fig. 57 Latin America Venous Stents Market Attractiveness, by Technology, 2017–2025
    Fig. 58 Latin America Venous Stents Market Value Share, by Application, 2017 and 2025
    Fig. 59 Latin America Venous Stents Market Attractiveness, by Application, 2017–2025
    Fig. 60 Latin America Venous Stents Market Value Share, by Disease Indication, 2017 and 2025
    Fig. 61 Latin America Venous Stents Market Attractiveness, by Disease Indication, 2017–2025
    Fig. 62 Middle East & Africa Venous Stents Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
    Fig. 63 Middle East & Africa Venous Stents Market Value Share, by Country/Sub-Region, 2017 and 2025
    Fig. 64 Middle East & Africa Venous Stents Market Attractiveness, by Country/Sub-Region, 2017–2025
    Fig. 65 Middle East & Africa Venous Stents Market Value Share, by Technology, 2017 and 2025
    Fig. 66 Middle East & Africa Venous Stents Market Attractiveness, by Technology, 2017–2025
    Fig. 67 Middle East & Africa Venous Stents Market Value Share, by Application, 2017 and 2025
    Fig. 68 Middle East & Africa Venous Stents Market Attractiveness, by Application, 2017–2025
    Fig. 69 Middle East & Africa Venous Stents Market Value Share, by Disease Indication, 2017 and 2025
    Fig. 70 Middle East & Africa Venous Stents Market Attractiveness, by Disease Indication, 2017–2025
    Fig. 71 Global Venous Stents Market Share, by Company, 2016
    Fig. 72 Boston Scientific Corporation Global Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
    Fig. 73 Boston Scientific Corporation Breakdown of Net Sales (%), by Region, 2016
    Fig. 74 C. R. Bard, Inc. Global Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2016
    Fig. 75 C. R. Bard, Inc. Breakdown of Net Sales (%), by Business Segment, 2016

Copyright © Transparency Market Research, Inc. All Rights reserved

Venous Stents Market

Schedule a Call